Answers are grounded in this paper and cite their sources.
SUMOylation is a reversible ubiquitin-like post-translational modification. It takes part in many cellular processes, including nucleocytoplasmic transport, transcriptional regulation, and protein homeostasis. Emerging evidence shows that the dynamic balance between SUMOylation and deSUMOylation is a key point for maintaining ocular development and visual function. Although eye diseases such as diabetic retinopathy, glaucoma, and cataract look different in the clinic, they often share the same molecular causes, like oxidative stress, chronic inflammation, and disrupted protein balance. SUMOylation is deeply involved in regulating all of these pathological pathways. This review therefore gives a systematic account of the enzymatic cascade of the SUMOylation system and its roles in ocular physiological development and in a range of ocular diseases. Finally, based on distinct pathological types, we discuss in a stratified manner the intervention strategies that target the SUMOylation pathway and their potential clinical prospects in ophthalmology.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: